Research by Vora in 2009 also produced similar results, namely recurrent breast cancer patients with higher vimentin levels compared to non-recurrent breast cancer, both in lobular and ductal breast cancer types [37, 40]. This evidence concerns the gene VIM and breast carcinoma.